[18F]fluorodeoxyglucose positron emission tomography in the management of lymphomas

Clin Lymphoma Myeloma. 2008 Oct;8(5):273-6. doi: 10.3816/CLM.2008.n.037.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Diagnosis, Differential
  • Disease Progression
  • Fluorodeoxyglucose F18*
  • Hodgkin Disease / diagnostic imaging*
  • Hodgkin Disease / drug therapy
  • Humans
  • Lymphoma, Non-Hodgkin / diagnostic imaging*
  • Lymphoma, Non-Hodgkin / drug therapy
  • Neoplasm Staging
  • Positron-Emission Tomography / instrumentation
  • Positron-Emission Tomography / methods*
  • Prognosis
  • Time Factors

Substances

  • Fluorodeoxyglucose F18